Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.
Eur J Cancer
; 196: 113425, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-38039778
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Melanoma
Limits:
Humans
Language:
En
Journal:
Eur J Cancer
Year:
2024
Type:
Article